Neal Swerdlow

Title(s)Recall Faculty, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Neal Swerdlow, M.D., Ph.D. is Distinguished Professor of Psychiatry and Director of the Research Residency Track in the Department of Psychiatry at the University of California, San Diego, School of Medicine. Dr. Swerdlow graduated Summa Cum Laude, Phi Beta Kappa, from Amherst College (Neuroscience) in 1981, received his M.D. and Ph.D. (Neuroscience) from UCSD in 1986, completed the UCSD Psychiatry Residency Program and joined the faculty of the Department of Psychiatry in 1991. Since that time, he has been continuously NIH-funded, was Director of the Psychiatry Core Clerkship for 17 years, directed separate clinical programs in the treatment of Obsessive Compulsive Disorder (OCD), Tourette Syndrome (TS) and Huntington's Disease (HD), and has directed the Psychiatry Research Residency Track since 2010.

    Research Interests: Dr. Swerdlow has published over 325 peer-reviewed research papers, 35 chapters and 1 book. His laboratories study the neural regulation of information processing and its deficiencies in schizophrenia, TS and OCD, and have been home to many dozens of students, from undergraduates to Fellows. Dr. Swerdlow’s career has focused heavily on service to our field and patients. For 10 years, he chaired the Tourette Syndrome Association Scientific Advisory Board, he served the San Diego NAMI for 10 years as a member of their Board of Directors and Chair of their Medical Advisory Board, has been a Program Chair for the American College of Neuropsychopharmacology, chaired and sat on many NIH review committees, was Associate Editor of Behavioral Neuroscience and Editorial Board member of several high-impact journals in our field. Neal is a past recipient of the APA Award for Research in Psychiatry, the ACNP Joel Elkes Award, APA Kempf Award, NAMI Judith Silver Award, TSA Champion of Children's Award, and the ACP Stanley Dean Award and Laughlin Fellowship, among other awards.

    Collapse Research 
    Collapse Research Activities and Funding
    Pharmacologic augmentation of targeted cognitive training in schizophrenia
    NIH R33MH123603Aug 6, 2020 - Jul 31, 2023
    Role: Principal Investigator
    Biomarker Predictors of Memantine Sensitivity in patients with Alzheimer's Disease
    NIH R01AG059640Sep 1, 2018 - May 31, 2023
    Role: Principal Investigator
    Psychiatric Research Residency Training Track
    NIH R25MH101072Jul 1, 2013 - Jun 30, 2023
    Role: Principal Investigator
    Memantine effects on sensorimotor gating and neurocognition in schizophrenia
    NIH R01MH094320Jun 8, 2012 - Mar 31, 2021
    Role: Principal Investigator
    Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
    NIH R34MH093453Jul 1, 2011 - Mar 31, 2015
    Role: Principal Investigator
    Genetics of individual differences in amphetamine effects on startle gating
    NIH R03DA027483Sep 1, 2009 - Aug 30, 2011
    Role: Principal Investigator
    Neuroscience at the Boundaries of Neurology and Psychiatry
    NIH R25MH076768Sep 30, 2005 - Aug 31, 2008
    Role: Principal Investigator
    Psychiatric Research Residency Training Track
    NIH R25MH074508Jul 27, 2005 - Jun 30, 2010
    Role: Principal Investigator
    A Simple Measure for Studying Sensory Gating Deficits
    NIH R01MH069589Jul 1, 2004 - Jun 30, 2009
    Role: Principal Investigator
    Neural Basis of Heritable DA-Mediated Gating Deficits
    NIH R01MH068366Jul 15, 2003 - Jun 30, 2011
    Role: Principal Investigator
    Pharmacologic augmentation of neurocognition and cognitive training in psychosis
    NIH R01MH059803May 1, 1999 - Apr 30, 2020
    Role: Principal Investigator
    III INTERNATIONAL SYMPOSIUM ON TOURETTE SYNDROME
    NIH R13NS038340Sep 25, 1998 - Aug 31, 1999
    Role: Principal Investigator
    Neural Circuitry of Sensorimotor Gating Across Species
    NIH K02MH001436Feb 1, 1997 - Jan 31, 2007
    Role: Principal Investigator
    Cortico-Striatal Substrates of Deficient Startle Gating
    NIH R01MH053484Jan 15, 1997 - Dec 31, 2010
    Role: Principal Investigator
    SEX DIFFERENCES IN SENSORIMOTOR MODULATION
    NIH R03MH054621Aug 1, 1996 - Jul 31, 1998
    Role: Principal Investigator
    STRIATO-PALLIDAL SUBSTRATES OF DEFICIENT STARTLE GATING
    NIH R29MH048381Sep 30, 1992 - Aug 31, 1997
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000827Mar 1, 1974 - Nov 30, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia. Psychol Med. 2024 Jul; 54(10):2669-2676. Molina JL, Joshi YB, Nungaray JA, Sprock J, Attarha M, Biagianti B, Thomas ML, Swerdlow NR, Light GA. PMID: 38587021.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers? Am J Psychiatry. 2024 Apr 01; 181(4):272-274. Light GA, Swerdlow NR. PMID: 38557145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker. Cogn Affect Behav Neurosci. 2024 Apr; 24(2):269-278. Noback M, Bhakta SG, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Light GA, Swerdlow NR, Brigman JL, Cavanagh JF, Young JW. PMID: 38168850; PMCID: PMC11060428.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    4. Prepulse inhibition and the call alert in emergency medical services. Psychophysiology. 2024 May; 61(5):e14508. Heathcote SD, Blumenthal TD, Swerdlow NR. PMID: 38164815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh. Am J Psychiatry. 2023 11 01; 180(11):841-842. Joshi Y, Swerdlow N, Light G. PMID: 37908092.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Click-train evoked steady state harmonic response as a novel pharmacodynamic biomarker of cortical oscillatory synchrony. Neuropharmacology. 2023 Dec 01; 240:109707. Gautam D, Raza MU, Miyakoshi M, Molina JL, Joshi YB, Clayson PE, Light GA, Swerdlow NR, Sivarao DV. PMID: 37673332.
      View in: PubMed   Mentions: 2     Fields:    
    7. The Relevance of Animal Models of Social Isolation and Social Motivation for Understanding Schizophrenia: Review and Future Directions. Schizophr Bull. 2023 09 07; 49(5):1112-1126. Powell SB, Swerdlow NR. PMID: 37527471; PMCID: PMC10483472.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    8. Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Mar; 9(3):346-355. Swerdlow NR, Gonzalez CE, Raza MU, Gautam D, Miyakoshi M, Clayson PE, Joshi YB, Molina JL, Talledo J, Thomas ML, Light GA, Sivarao DV. PMID: 37683728.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    9. Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders. Psychiatry Res. 2023 09; 327:115215. Joshi YB, Gonzalez CE, Molina JL, MacDonald LR, Min Din J, Minhas J, Leposke T, Nordberg B, Li F, Talledo J, Sprock J, Swerdlow NR, Light GA. PMID: 37406367.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. Am J Psychiatry. 2023 07 01; 180(7):519-523. Joshi YB, Molina JL, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 37038743.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease. J Alzheimers Dis. 2023; 91(1):355-362. Swerdlow NR, Joshi YB, Sprock J, Talledo J, Molina JL, Delano-Wood L, Iwanaga D, Kotz JE, Huege S, Léger GC, Light GA. PMID: 36404550.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Correction to: Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Transl Psychiatry. 2022 Jul 21; 12(1):290. Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. PMID: 35864090; PMCID: PMC9304120.
      View in: PubMed   Mentions:    Fields:    
    13. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 04; 604(7906):502-508. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fañanás L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, González Peñas J, González-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Gülöksüz S, Gur RE, Gur RC, Gutiérrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julià A, Kähler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kucinskas V, Kucinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lönnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntané G, Murphy KC, Myin-Germeys I, Nenadic I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O'Brien NL, O'Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietiläinen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Söderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stögmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Üçok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbasoglu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, Byerley WF, Chen WJ, Cloninger CR, Crespo-Facorro B, et al. PMID: 35396580; PMCID: PMC9392466.
      View in: PubMed   Mentions: 684     Fields:    Translation:Humans
    14. Amphetamine alters an EEG marker of reward processing in humans and mice. Psychopharmacology (Berl). 2022 Mar; 239(3):923-933. Cavanagh JF, Olguin SL, Talledo JA, Kotz JE, Roberts BZ, Nungaray JA, Sprock J, Gregg D, Bhakta SG, Light GA, Swerdlow NR, Young JW, Brigman JL. PMID: 35132440; PMCID: PMC8891070.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    15. EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants. Neuropsychopharmacology. 2022 04; 47(5):1029-1036. Bhakta SG, Cavanagh JF, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Brigman JL, Light GA, Swerdlow NR, Young JW. PMID: 35042948; PMCID: PMC8938448.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia. Psychiatry Res. 2021 11; 305:114239. Clayson PE, Molina JL, Joshi YB, Thomas ML, Sprock J, Nungaray J, Swerdlow NR, Light GA. PMID: 34673326.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Transl Psychiatry. 2021 09 17; 11(1):482. Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. PMID: 34535625; PMCID: PMC8448772.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    18. Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training. Schizophr Res. 2021 10; 236:135-141. Molina JL, Joshi YB, Nungaray JA, Thomas ML, Sprock J, Clayson PE, Sanchez VA, Attarha M, Biagianti B, Swerdlow NR, Light GA. PMID: 34500174; PMCID: PMC9259506.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophr Res. 2022 05; 243:372-382. Clayson PE, Joshi YB, Thomas ML, Tarasenko M, Bismark A, Sprock J, Nungaray J, Cardoso L, Wynn JK, Swerdlow NR, Light GA. PMID: 34187732.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. Am J Psychiatry. 2021 09 01; 178(9):838-847. Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 33985348; PMCID: PMC8440496.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    21. Detecting the Inverted-U in fMRI Studies of Schizophrenia: A Comparison of Three Analysis Methods. J Int Neuropsychol Soc. 2022 03; 28(3):258-269. Thomas ML, Duffy JR, Swerdlow N, Light GA, Brown GG. PMID: 33949299; PMCID: PMC8568731.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course. Psychol Med. 2023 01; 53(1):140-148. Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Vinogradov S, Molina JL, Light GA. PMID: 33849683; PMCID: PMC8514598.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophr Bull. 2021 03 16; 47(2):373-385. Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32856089; PMCID: PMC7965084.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    24. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia. Schizophr Res. 2021 02; 228:280-287. Koshiyama D, Miyakoshi M, Thomas ML, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 33493776.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    25. Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration. J Alzheimers Dis. 2021; 84(4):1431-1438. Swerdlow NR, Kotz JE, Joshi YB, Talledo J, Sprock J, Molina JL, Huisa B, Huege SF, Romero JA, Walsh MJ, Delano-Wood L, Light GA. PMID: 34690144; PMCID: PMC8881988.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Neural network dynamics underlying gamma synchronization deficits in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2021 04 20; 107:110224. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Braff DL, Swerdlow NR, Light GA. PMID: 33340619; PMCID: PMC8631608.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia. Transl Psychiatry. 2020 11 23; 10(1):405. Molina JL, Thomas ML, Joshi YB, Hochberger WC, Koshiyama D, Nungaray JA, Cardoso L, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 33230190; PMCID: PMC7684295.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    28. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia. Schizophr Res. 2020 10; 224:33-39. Greenwood TA, Swerdlow NR, Sprock J, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Duncan E. PMID: 33189519; PMCID: PMC7728376.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology. 2020 12; 45(13):2180-2188. Swerdlow NR, Bhakta SG, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas ML, Joshi YB, Molina JL, Light GA. PMID: 32961542; PMCID: PMC7784956.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology. 2020 12; 45(13):2198-2206. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32829382; PMCID: PMC7784692.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    31. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 11; 5(11):1028-1039. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32830097.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    32. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. PLoS One. 2020; 15(5):e0232855. Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL. PMID: 32401791; PMCID: PMC7219730.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    33. Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. Psychopharmacology (Berl). 2020 Jul; 237(7):1959-1972. Young JW, Roberts BZ, Breier M, Swerdlow NR. PMID: 32318751.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    34. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 06; 5(6):562-568. Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. PMID: 32340927; PMCID: PMC7286803.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    35. Selection criteria for neurophysiologic biomarkers to accelerate the pace of CNS therapeutic development. Neuropsychopharmacology. 2020 01; 45(1):237-238. Light GA, Swerdlow NR. PMID: 31506611; PMCID: PMC6879638.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    36. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. JAMA Psychiatry. 2019 12 01; 76(12):1274-1284. Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL. PMID: 31596458; PMCID: PMC6802253.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    37. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophr Res. 2020 01; 215:97-104. Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. PMID: 31759809; PMCID: PMC7035985.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning. Schizophr Res. 2020 01; 215:300-307. Hochberger WC, Thomas ML, Joshi YB, Swerdlow NR, Braff DL, Gur RE, Gur RC, Light GA, Consortium of Genomics in Schizophrenia (COGS) investigators. PMID: 31744751.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Commentary: Lessons Learned From Animal Models for Schizophrenia. Am J Geriatr Psychiatry. 2020 01; 28(1):20-22. Swerdlow NR. PMID: 31542196.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    40. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology. 2019 12; 44(13):2277-2284. Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. PMID: 31445502; PMCID: PMC6897898.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia. Proc Natl Acad Sci U S A. 2019 02 26; 116(9):3847-3852. Lainscsek C, Sampson AL, Kim R, Thomas ML, Man K, Lainscsek X, COGS Investigators, Swerdlow NR, Braff DL, Sejnowski TJ, Light GA. PMID: 30808768; PMCID: PMC6397565.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    42. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophr Res. 2019 06; 208:384-389. Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. PMID: 30738698; PMCID: PMC8215853.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophr Res. 2019 08; 210:215-220. Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. PMID: 30660574; PMCID: PMC7032664.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning. Int J Psychophysiol. 2019 11; 145:23-29. Hochberger WC, Joshi YB, Zhang W, Thomas ML, Consortium of Genomics in Schizophrenia (COGS) investigators, Braff DL, Swerdlow NR, Light GA. PMID: 30586570; PMCID: PMC7261144.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    45. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology. 2019 02; 44(3):606-612. Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. PMID: 30377381; PMCID: PMC6333927.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    46. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophr Res. 2018 12; 202:378-384. Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, Light GA. PMID: 30055883; PMCID: PMC7409526.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    47. Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. Schizophr Res. 2018 09; 199:285-291. Swerdlow NR, Bhakta SG, Light GA. PMID: 29627173; PMCID: PMC6151271.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    48. Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates. Schizophr Res. 2018 08; 198:1-5. Swerdlow NR, Light GA. PMID: 29525460; PMCID: PMC6103885.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    49. Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 07; 3(7):581-590. Kantrowitz JT, Swerdlow NR, Dunn W, Vinogradov S. PMID: 29656951; PMCID: PMC6062454.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    50. Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors. Int J Neuropsychopharmacol. 2017 12 01; 20(12):979-987. Bhakta SG, Light GA, Talledo JA, Balvaneda B, Hughes E, Alvarez A, Rana BK, Young JW, Swerdlow NR. PMID: 29020372; PMCID: PMC5716101.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    51. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Neuropsychopharmacology. 2018 03; 43(4):708-717. Swerdlow NR, Bhakta SG, Talledo JA, Franz DM, Hughes EL, Rana BK, Light GA. PMID: 29154367; PMCID: PMC5809803.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. A Upf3b-mutant mouse model with behavioral and neurogenesis defects. Mol Psychiatry. 2018 08; 23(8):1773-1786. Huang L, Shum EY, Jones SH, Lou CH, Chousal J, Kim H, Roberts AJ, Jolly LA, Espinoza JL, Skarbrevik DM, Phan MH, Cook-Andersen H, Swerdlow NR, Gecz J, Wilkinson MF. PMID: 28948974; PMCID: PMC5869067.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    53. Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophr Bull. 2017 07 01; 43(4):872-880. Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA. PMID: 27798224; PMCID: PMC5472129.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    54. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophr Res. 2018 08; 198:6-15. Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 28549722; PMCID: PMC5700873.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    55. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology. 2017 Dec; 42(13):2633-2639. Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. PMID: 28425497; PMCID: PMC5686499.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    56. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia. Neuropsychopharmacology. 2017 Oct; 42(11):2206-2213. Perez VB, Tarasenko M, Miyakoshi M, Pianka ST, Makeig SD, Braff DL, Swerdlow NR, Light GA. PMID: 28139679; PMCID: PMC5603809.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    57. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. JAMA Psychiatry. 2017 Jan 01; 74(1):37-46. Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, Silverman JM, Sprock J, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Light GA. PMID: 27926742; PMCID: PMC5453308.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    58. Sensorimotor gating in healthy adults tested over a 15 year period. Biol Psychol. 2017 02; 123:177-186. Swerdlow NR, Bhakta SG, Rana BK, Kei J, Chou HH, Talledo JA. PMID: 28027936; PMCID: PMC5297597.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next. J Psychopharmacol. 2016 11; 30(11):1072-1081. Swerdlow NR, Braff DL, Geyer MA. PMID: 27539931; PMCID: PMC6036900.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimals
    60. Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology (Berl). 2016 Oct; 233(19-20):3513-25. Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, Geyer MA, Young JW. PMID: 27534540; PMCID: PMC5023490.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    61. Treat and Teach Our Students Well: College Mental Health and Collaborative Campus Communities. Psychiatr Serv. 2016 09 01; 67(9):957-63. Downs NS, Alderman T, Schneiber K, Swerdlow NR. PMID: 27181737.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophr Res. 2016 07; 174(1-3):1-9. Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW. PMID: 27132484; PMCID: PMC4912929.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. Psychopharmacology (Berl). 2016 06; 233(12):2399-410. Bhakta SG, Chou HH, Rana B, Talledo JA, Balvaneda B, Gaddis L, Light GA, Swerdlow NR. PMID: 27076209; PMCID: PMC5214934.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    64. Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia. Schizophr Res. 2016 Apr; 172(1-3):123-30. Tarasenko M, Perez VB, Pianka ST, Vinogradov S, Braff DL, Swerdlow NR, Light GA. PMID: 26851143; PMCID: PMC5072522.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    65. Reawakening research on reducing shock pain. Heart Rhythm. 2016 05; 13(5):1149-1150. Swerdlow CD, Blumenthal T, Swerdlow NR. PMID: 26795457.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant? Curr Top Behav Neurosci. 2016; 28:305-25. Swerdlow NR, Light GA. PMID: 27311762.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    67. Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine. Cogn Affect Behav Neurosci. 2015 Dec; 15(4):901-14. Amitai N, Powell S, Weber M, Swerdlow NR, Young JW. PMID: 26220402; PMCID: PMC4641795.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    68. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophr Res. 2016 Jan; 170(1):30-40. Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 26597662; PMCID: PMC4707095.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    69. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. Am J Psychiatry. 2016 Apr 01; 173(4):385-91. Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 26441157; PMCID: PMC4933520.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    70. Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology. 2016 Jan; 41(2):419-30. Swerdlow NR, Bhakta S, Chou HH, Talledo JA, Balvaneda B, Light GA. PMID: 26062785; PMCID: PMC5130118.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    71. Bending the curve on psychosis outcomes. Lancet Psychiatry. 2015 May; 2(5):365-367. Light GA, Swerdlow NR. PMID: 26360262; PMCID: PMC5072396.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    72. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophr Res. 2015 Apr; 163(1-3):17-23. Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Gur RE. PMID: 25432636; PMCID: PMC4441547.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    73. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Ann N Y Acad Sci. 2015 May; 1344:105-19. Light GA, Swerdlow NR. PMID: 25752648; PMCID: PMC4412775.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimals
    74. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):38-46. Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 25749017; PMCID: PMC4382444.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    75. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophr Res. 2015 Apr; 163(1-3):73-9. Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 25682549; PMCID: PMC5944296.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    76. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophr Res. 2015 Apr; 163(1-3):47-52. Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Sugar CA, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 25553977; PMCID: PMC4382408.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    77. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):32-7. Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Seidman LJ. PMID: 25497440; PMCID: PMC5954831.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    78. Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this Special Issue of Schizophrenia Research. Schizophr Res. 2015 Apr; 163(1-3):9-16. Swerdlow NR, Gur RE, Braff DL. PMID: 25454799; PMCID: PMC4382419.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    79. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res. 2015 Apr; 163(1-3):63-72. Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI. PMID: 25449710; PMCID: PMC4382452.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    80. The auditory brain-stem response to complex sounds: a potential biomarker for guiding treatment of psychosis. Front Psychiatry. 2014; 5:142. Tarasenko MA, Swerdlow NR, Makeig S, Braff DL, Light GA. PMID: 25352811; PMCID: PMC4195270.
      View in: PubMed   Mentions: 12  
    81. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophr Res. 2015 Apr; 163(1-3):53-62. Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Light G. PMID: 25306203; PMCID: PMC4382423.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    82. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophr Res. 2015 Apr; 163(1-3):24-31. Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 25248939; PMCID: PMC4368500.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    83. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophr Bull. 2014 Nov; 40(6):1404-11. Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 24903414; PMCID: PMC4193725.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    84. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Res. 2014 Sep 30; 219(1):67-71. Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Stone WS, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Silverman JM. PMID: 24913833; PMCID: PMC4110721.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? PLoS One. 2014; 9(2):e88379. Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone W, Sprock J, Sugar C, Swerdlow N, Tsuang M, Turetsky B, Radant A. PMID: 24523888; PMCID: PMC3921166.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    86. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr Res. 2014 Feb; 152(2-3):503-12. Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 24405980; PMCID: PMC3960985.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    87. Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. Biomark Med. 2014; 8(1):9-14. Perez VB, Swerdlow NR, Braff DL, Näätänen R, Light GA. PMID: 24325220; PMCID: PMC4043396.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    88. Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle. Curr Top Behav Neurosci. 2014; 21:293-314. Light GA, Swerdlow NR. PMID: 24850080; PMCID: PMC5951188.
      View in: PubMed   Mentions: 15     Fields:    
    89. Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. Behav Brain Res. 2013 Nov 15; 257:118-28. Swerdlow NR, Light GA, Trim RS, Breier MR, Hines SR, Powell SB. PMID: 24076151; PMCID: PMC3897308.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    90. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 2013 Aug 01; 154(3):518-29. Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H, Consortium on the Genetics of Schizophrenia (COGS), PAARTNERS Study Group, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM. PMID: 23911319; PMCID: PMC3894107.
      View in: PubMed   Mentions: 326     Fields:    Translation:HumansCells
    91. Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats. Neuropharmacology. 2013 Dec; 75:38-46. Swerdlow NR, Powell SB, Breier MR, Hines SR, Light GA. PMID: 23810830; PMCID: PMC3825835.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    92. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2013 May; 170(5):521-32. Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL. PMID: 23511790; PMCID: PMC3878873.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    93. Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains. Pharmacol Biochem Behav. 2013 May; 106:128-31. Swerdlow NR, Hines SR, Herrera SD, Weber M, Breier MR. PMID: 23567203; PMCID: PMC3760336.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    94. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry. 2013 May 15; 73(10):976-84. Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Lazzeroni LC, Gur RE. PMID: 23395246; PMCID: PMC3954126.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    95. Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults. Psychopharmacology (Berl). 2013 May; 227(1):165-76. Chou HH, Talledo JA, Lamb SN, Thompson WK, Swerdlow NR. PMID: 23314393; PMCID: PMC3624060.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    96. Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev. 2013 Jul; 37(6):1150-6. Swerdlow NR. PMID: 23017868; PMCID: PMC3566359.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    97. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neurosci Biobehav Rev. 2013 Jul; 37(6):1139-49. Amitai N, Weber M, Swerdlow NR, Sharp RF, Breier MR, Halberstadt AL, Young JW. PMID: 23010529; PMCID: PMC3556379.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    98. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PLoS One. 2012; 7(7):e39434. Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL. PMID: 22802938; PMCID: PMC3389010.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    99. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology (Berl). 2012 Dec; 224(3):349-62. Swerdlow NR, Shilling PD, Breier M, Trim RS, Light GA, Marie RS. PMID: 22700037; PMCID: PMC5215002.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    100. Disentangling early sensory information processing deficits in schizophrenia. Clin Neurophysiol. 2012 Oct; 123(10):1942-9. Rissling AJ, Braff DL, Swerdlow NR, Hellemann G, Rassovsky Y, Sprock J, Pela M, Light GA. PMID: 22608970; PMCID: PMC3436955.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    101. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Dev Neurosci. 2012; 34(2-3):240-9. Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. PMID: 22572564.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    102. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biol Psychiatry. 2012 May 15; 71(10):873-80. Kirihara K, Rissling AJ, Swerdlow NR, Braff DL, Light GA. PMID: 22361076; PMCID: PMC3434875.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    103. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS One. 2012; 7(1):e29630. Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL. PMID: 22253750; PMCID: PMC3258248.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    104. Beyond antipsychotics: pharmacologically-augmented cognitive therapies (PACTs) for schizophrenia. Neuropsychopharmacology. 2012 Jan; 37(1):310-1. Swerdlow NR. PMID: 22157876; PMCID: PMC3238077.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    105. Towards medication-enhancement of cognitive interventions in schizophrenia. Handb Exp Pharmacol. 2012; (213):81-111. Chou HH, Twamley E, Swerdlow NR. PMID: 23027413; PMCID: PMC3629915.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    106. Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats. Brain Res. 2012 Feb 09; 1437:69-76. Chang WL, Weber M, Breier MR, Saint Marie RL, Hines SR, Swerdlow NR. PMID: 22227455; PMCID: PMC3268831.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    107. Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats. Pharmacol Biochem Behav. 2011 Oct; 99(4):634-8. Chang WL, Breier MR, Yang A, Swerdlow NR. PMID: 21683731; PMCID: PMC5946323.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    108. Are we studying and treating schizophrenia correctly? Schizophr Res. 2011 Aug; 130(1-3):1-10. Swerdlow NR. PMID: 21645998; PMCID: PMC3139794.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    109. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011 Sep; 168(9):930-46. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 21498463; PMCID: PMC3751972.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    110. Sensory gating scales and premonitory urges in Tourette syndrome. ScientificWorldJournal. 2011 Mar 22; 11:736-41. Sutherland Owens AN, Miguel EC, Swerdlow NR. PMID: 21442151; PMCID: PMC5548288.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    111. Probing the molecular basis for an inherited sensitivity to the startle-gating disruptive effects of apomorphine in rats. Psychopharmacology (Berl). 2011 Aug; 216(3):401-10. Swerdlow NR, Breier MR, Saint Marie RL. PMID: 21365203; PMCID: PMC5944297.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    112. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2011 May; 128(1-3):102-10. Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Roe AH, Schork NJ, Siever LJ, Silverman JM, Swerdlow NR, Thomas AR, Tsuang DW, Turetsky BI, Seidman LJ. PMID: 21288694; PMCID: PMC6819951.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    113. Electroencephalography (EEG) and event-related potentials (ERPs) with human participants. Curr Protoc Neurosci. 2010 Jul; Chapter 6:Unit 6.25.1-24. Light GA, Williams LE, Minow F, Sprock J, Rissling A, Sharp R, Swerdlow NR, Braff DL. PMID: 20578033; PMCID: PMC2909037.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    114. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res. 2010 Jun; 119(1-3):175-82. Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R. PMID: 20382002; PMCID: PMC3688282.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    115. Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats. Pharmacol Biochem Behav. 2010 Jun; 95(4):473-8. Chang WL, Swerdlow NR, Breier MR, Thangaraj N, Weber M. PMID: 20385162; PMCID: PMC2889248.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    116. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 2010 Sep; 47(5):846-56. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 20374545; PMCID: PMC4176871.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    117. The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. Eur Neuropsychopharmacol. 2010 Jun; 20(6):421-5. Weber M, Chang WL, Breier MR, Yang A, Millan MJ, Swerdlow NR. PMID: 20346635; PMCID: PMC2864324.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    118. Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience. 2010 Jun 30; 168(2):498-504. Saint Marie RL, Miller EJ, Breier MR, Weber M, Swerdlow NR. PMID: 20338222; PMCID: PMC2887283.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    119. The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice. Behav Pharmacol. 2010 Mar; 21(2):135-43. Chang WL, Geyer MA, Buell MR, Weber M, Swerdlow NR. PMID: 20215963; PMCID: PMC2890261.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    120. Pathways from the ventral hippocampus and caudal amygdala to forebrain regions that regulate sensorimotor gating in the rat. Neuroscience. 2010 Jan 20; 165(2):601-11. Miller EJ, Saint Marie LR, Breier MR, Swerdlow NR. PMID: 19854244; PMCID: PMC2796367.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    121. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats. Behav Brain Res. 2010 Apr 02; 208(2):560-5. Breier MR, Lewis B, Shoemaker JM, Light GA, Swerdlow NR. PMID: 20080128; PMCID: PMC2834557.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    122. Integrative circuit models and their implications for the pathophysiologies and treatments of the schizophrenias. Curr Top Behav Neurosci. 2010; 4:555-83. Swerdlow NR. PMID: 21312413.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    123. Behavioral neurobiology of schizophrenia and its treatment. Preface. Curr Top Behav Neurosci. 2010; 4:v-vii. Swerdlow NR. PMID: 21312394.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    124. Behavioral Neurobiology of Schizophrenia and Its Treatment. 2010; 1-657. Swerdlow NR (Ed.).
    125. Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats. Psychopharmacology (Berl). 2009 Dec; 207(2):271-80. Qu Y, Saint Marie RL, Breier MR, Ko D, Stouffer D, Parsons LH, Swerdlow NR. PMID: 19756524; PMCID: PMC2770636.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    126. Pramipexole effects on startle gating in rats and normal men. Psychopharmacology (Berl). 2009 Sep; 205(4):689-98. Swerdlow NR, Lelham SA, Sutherland Owens AN, Chang WL, Sassen SD, Talledo JA. PMID: 19506839; PMCID: PMC2718192.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    127. Effects of the first prepulse on the blink response to a startling noise. Behav Neurosci. 2009 Jun; 123(3):607-13. Swerdlow NR, Talledo JA. PMID: 19485567; PMCID: PMC5944322.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacol Biochem Behav. 2009 Aug; 93(2):141-7. Weber M, Chang WL, Durbin JP, Park PE, Luedtke RR, Mach RH, Swerdlow NR. PMID: 19426754; PMCID: PMC2720754.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    129. The effects of memantine on prepulse inhibition. Neuropsychopharmacology. 2009 Jun; 34(7):1854-64. Swerdlow NR, van Bergeijk DP, Bergsma F, Weber E, Talledo J. PMID: 19242406; PMCID: PMC2680939.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    130. Amphetamine effects on startle gating in normal women and female rats. Psychopharmacology (Berl). 2009 May; 204(1):165-75. Talledo JA, Sutherland Owens AN, Schortinghuis T, Swerdlow NR. PMID: 19148623; PMCID: PMC2717706.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    131. Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine. Psychopharmacology (Berl). 2009 May; 203(4):723-35. Weber M, Breier M, Ko D, Thangaraj N, Marzan DE, Swerdlow NR. PMID: 19066855; PMCID: PMC2748940.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    132. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behav Pharmacol. 2008 Dec; 19(8):786-95. Weber M, Chang WL, Breier M, Ko D, Swerdlow NR. PMID: 19020413; PMCID: PMC3255557.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    133. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacol Biochem Behav. 2008 Oct; 90(4):686-90. Qu Y, Swerdlow NR, Weber M, Stouffer D, Parsons LH. PMID: 18579193; PMCID: PMC3250091.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    134. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry. 2008 Dec 15; 64(12):1051-9. Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Calkins ME. PMID: 18701089; PMCID: PMC2653714.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    135. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl). 2008 Aug; 199(3):331-88. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. PMID: 18568339; PMCID: PMC2771731.
      View in: PubMed   Mentions: 251     Fields:    Translation:HumansAnimals
    136. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):218-28. Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 18406578; PMCID: PMC2529172.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    137. Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways. Biol Psychiatry. 2008 Apr 15; 63(8):748-58. Shilling PD, Saint Marie RL, Shoemaker JM, Swerdlow NR. PMID: 18083141; PMCID: PMC2771724.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    138. Advances in endophenotyping schizophrenia. World Psychiatry. 2008 Feb; 7(1):11-8. Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ, Investigators of the Consortium on the Genetics of Schizophrenia. PMID: 18458787; PMCID: PMC2359727.
      View in: PubMed   Mentions: 39  
    139. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry. 2007 Nov; 64(11):1242-50. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. PMID: 17984393; PMCID: PMC10588564.
      View in: PubMed   Mentions: 186     Fields:    Translation:Humans
    140. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci. 2007 Oct; 19(10):1624-32. Light GA, Swerdlow NR, Braff DL. PMID: 18271737; PMCID: PMC2562660.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    141. Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses. Pharmacol Biochem Behav. 2008 Jan; 88(3):306-11. Weber M, Swerdlow NR. PMID: 17900675; PMCID: PMC2266874.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    142. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacol Biochem Behav. 2008 Jan; 88(3):280-90. Swerdlow NR, Breier M, Mora AB, Ko D, Shoemaker JM. PMID: 17936348; PMCID: PMC2585785.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    143. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration. Pharmacol Biochem Behav. 2007 May; 87(1):1-10. Swerdlow NR, Shoemaker JM, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. PMID: 17475315; PMCID: PMC1995415.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    144. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2007 May; 92(1-3):237-51. Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17346930; PMCID: PMC2039885.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    145. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm (Vienna). 2007 Jul; 114(7):893-8. Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP. PMID: 17594127.
      View in: PubMed   Mentions: 68     Fields:    Translation:AnimalsCells
    146. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry. 2007 May 15; 61(10):1204-7. Braff DL, Light GA, Swerdlow NR. PMID: 17161386.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    147. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry. 2006 Dec; 63(12):1325-35. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. PMID: 17146007.
      View in: PubMed   Mentions: 156     Fields:    Translation:Humans
    148. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull. 2007 Jan; 33(1):69-94. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. PMID: 17135482; PMCID: PMC2632291.
      View in: PubMed   Mentions: 216     Fields:    Translation:Humans
    149. Effects of prepulse intensity, duration, and bandwidth on perceived intensity of startling acoustic stimuli. Biol Psychol. 2007 Mar; 74(3):389-95. Swerdlow NR, Blumenthal TD, Sutherland AN, Weber E, Talledo JA. PMID: 17118517; PMCID: PMC1992603.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    150. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology (Berl). 2007 Feb; 190(2):201-11. Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, Winey KI, Swerdlow NR, Siegel SJ. PMID: 17119931.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    151. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006 Nov; 21(11):1831-8. Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL, Tourette Syndrome Association, Inc. PMID: 16991144.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    152. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull. 2007 Jan; 33(1):33-48. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17035358; PMCID: PMC2632302.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    153. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):320-9. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 17023145.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    154. The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny. Brain Res. 2006 Nov 13; 1119(1):203-14. Saint Marie RL, Neary AC, Shoemaker JM, Swerdlow NR. PMID: 16979142.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    155. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol Psychiatry. 2006 Dec 01; 60(11):1231-40. Light GA, Hsu JL, Hsieh MH, Meyer-Gomes K, Sprock J, Swerdlow NR, Braff DL. PMID: 16893524.
      View in: PubMed   Mentions: 194     Fields:    Translation:Humans
    156. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Neurosci Lett. 2006 Jul 10; 402(1-2):40-5. Swerdlow NR, Shoemaker JM, Kuczenski R, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. PMID: 16644125.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    157. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function. Neuropsychopharmacology. 2006 Apr; 31(4):721-9. Swerdlow NR, Krupin AS, Bongiovanni MJ, Shoemaker JM, Goins JC, Hammer RP. PMID: 16123742; PMCID: PMC1403813.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    158. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl). 2006 Jun; 186(2):246-54. Swerdlow NR, Bongiovanni MJ, Tochen L, Shoemaker JM. PMID: 16583235.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    159. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology. 2006 Mar; 31(3):506-15. Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP. PMID: 16123772; PMCID: PMC1373667.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    160. Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats. Neuropsychopharmacology. 2006 Sep; 31(9):2011-21. Swerdlow NR, Talledo J, Sutherland AN, Nagy D, Shoemaker JM. PMID: 16482083.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    161. Prepulse-elicited motor reactions do not differ between schizophrenia patients and control subjects. Behav Neurosci. 2006 Feb; 120(1):224-7. Swerdlow NR, Sprock J, Braff DL. PMID: 16492135.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    162. Preclinical models relevant to Tourette syndrome. Adv Neurol. 2006; 99:69-88. Swerdlow NR, Sutherland AN. PMID: 16536353.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    163. Reduced startle gating after D1 blockade: effects of concurrent D2 blockade. Pharmacol Biochem Behav. 2005 Oct; 82(2):293-9. Swerdlow NR, Shoemaker JM, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. PMID: 16188305; PMCID: PMC1364453.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    164. Effects of background and prepulse characteristics on prepulse inhibition and facilitation: implications for neuropsychiatric research. Biol Psychiatry. 2006 Mar 15; 59(6):555-9. Hsieh MH, Swerdlow NR, Braff DL. PMID: 16169529.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    165. Tourette syndrome: current controversies and the battlefield landscape. Curr Neurol Neurosci Rep. 2005 Sep; 5(5):329-31. Swerdlow NR. PMID: 16131414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    166. Using animal models to develop therapeutics for Tourette Syndrome. Pharmacol Ther. 2005 Dec; 108(3):281-93. Swerdlow NR, Sutherland AN. PMID: 15970330.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    167. Prepulse inhibition of perceived stimulus intensity: paradigm assessment. Biol Psychol. 2005 May; 69(2):133-47. Swerdlow NR, Stephany NL, Talledo J, Light G, Braff DL, Baeyens D, Auerbach PP. PMID: 15804542.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    168. Female schizophrenia patients have prepulse inhibition deficits. Biol Psychiatry. 2005 Apr 01; 57(7):817-20. Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR. PMID: 15820241.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    169. Startle modulation in Caucasian-Americans and Asian-Americans: a prelude to genetic/endophenotypic studies across the 'Pacific Rim'. Psychiatr Genet. 2005 Mar; 15(1):61-5. Swerdlow NR, Talledo JA, Braff DL. PMID: 15722959.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    170. Much ado about (almost) nothing: response to 'prepulse lost and regained'. Psychopharmacology (Berl). 2005 Jun; 179(4):893-4. Swerdlow NR. PMID: 15645219.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    171. Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats. Neuroscience. 2005; 135(2):385-94. Shoemaker JM, Saint Marie RL, Bongiovanni MJ, Neary AC, Tochen LS, Swerdlow NR. PMID: 16125865; PMCID: PMC1364454.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    172. Intact visual latent inhibition in schizophrenia patients in a within-subject paradigm. Schizophr Res. 2005 Jan 01; 72(2-3):169-83. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Minassian A, Auerbach PP. PMID: 15560962.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    173. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacol Biochem Behav. 2005 Feb; 80(2):203-11. Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, Shoemaker JM. PMID: 15680173.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    174. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation. Biol Psychiatry. 2004 Aug 15; 56(4):296-9. Harte MK, Powell SB, Reynolds LM, Swerdlow NR, Geyer MA, Reynolds GP. PMID: 15312819.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    175. Weak prepulses inhibit but do not elicit startle in rats and humans. Biol Psychiatry. 2004 Jun 15; 55(12):1195-8. Swerdlow NR, Talledo J, Shoemaker JM, Codon K, Goins J, Auerbach PP. PMID: 15184039.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
    176. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains. Pharmacol Biochem Behav. 2004 Feb; 77(2):291-302. Swerdlow NR, Shoemaker JM, Crain S, Goins J, Onozuka K, Auerbach PP. PMID: 14751457.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    177. The ventral hippocampal regulation of prepulse inhibition and its disruption by apomorphine in rats are not mediated via the fornix. Neuroscience. 2004; 123(3):675-85. Swerdlow NR, Shoemaker JM, Noh HR, Ma L, Gaudet I, Munson M, Crain S, Auerbach PP. PMID: 14706779.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    178. Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharmacology (Berl). 2004 Aug; 174(4):441-51. Swerdlow NR, Shoemaker JM, Platten A, Pitcher L, Goins J, Auerbach PP. PMID: 15300358.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    179. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology (Berl). 2004 Aug; 174(4):452-62. Swerdlow NR, Shoemaker JM, Auerbach PP, Pitcher L, Goins J, Platten A. PMID: 15300359.
      View in: PubMed   Mentions: 29     Fields:    Translation:Animals
    180. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Pharmacol Biochem Behav. 2003 Apr; 75(1):191-7. Swerdlow NR, Shoemaker JM, Platten A, Pitcher L, Goins J, Crain S. PMID: 12759127.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    181. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology (Berl). 2003 Sep; 169(3-4):314-20. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Auerbach PP. PMID: 12610717.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    182. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology. 2003 Feb; 28(2):226-34. Swerdlow NR, Platten A, Hanlon FM, Martinez ZA, Printz MP, Auerbach P. PMID: 12589375.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    183. Quetiapine produces a prolonged reversal of the sensorimotor gating-disruptive effects of basolateral amygdala lesions in rats. Behav Neurosci. 2003 Feb; 117(1):136-43. Shoemaker JM, Pitcher L, Noh HR, Swerdlow NR. PMID: 12619916.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    184. Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Biol Psychol. 2003 Jan; 62(1):17-26. Swerdlow NR, Wasserman LC, Talledo JA, Casas R, Bruins P, Stephany NL. PMID: 12505765.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    185. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience. 2003; 119(1):233-40. Powell SB, Geyer MA, Preece MA, Pitcher LK, Reynolds GP, Swerdlow NR. PMID: 12763084.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    186. Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus. Brain Res. 2002 Oct 25; 953(1-2):246-54. Swerdlow NR, Pitcher L, Noh HR, Shoemaker JM. PMID: 12384258.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    187. Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Neuropsychopharmacology. 2003 Apr; 28(4):640-50. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Shoemaker J, Auerbach PP. PMID: 12655308.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    188. Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiol Behav. 2002 Sep; 77(1):55-64. Powell SB, Swerdlow NR, Pitcher LK, Geyer MA. PMID: 12213502.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    189. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology (Berl). 2002 Oct; 164(1):82-92. Swerdlow NR, Stephany N, Shoemaker JM, Ross L, Wasserman LC, Talledo J, Auerbach PP. PMID: 12373422.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    190. Prestimulus effects on startle magnitude: sensory or motor? Behav Neurosci. 2002 Aug; 116(4):672-81. Swerdlow NR, Shoemaker JM, Stephany N, Wasserman L, Ro HJ, Geyer MA. PMID: 12148934.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    191. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Behav Neurosci. 2002 Aug; 116(4):682-90. Swerdlow NR, Shoemaker JM, Pitcher L, Platten A, Kuczenski R, Eleey CC, Auerbach P. PMID: 12148935.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    192. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology (Berl). 2002 May; 161(2):189-201. Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP. PMID: 11981599.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    193. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats. Psychopharmacology (Berl). 2002 Apr; 161(1):38-46. Martinez ZA, Platten A, Pollack E, Shoemaker J, Ro H, Pitcher L, Geyer MA, Swerdlow NR. PMID: 11967629.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    194. Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl). 2001 Nov; 158(3):230-40. Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P. PMID: 11713612.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    195. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry. 2001 Oct 15; 50(8):578-85. Swerdlow NR, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A. PMID: 11690592.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    196. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants. Pharmacol Biochem Behav. 2001 Oct-Nov; 70(2-3):219-26. Swerdlow NR, Platten A, Kim YK, Gaudet I, Shoemaker J, Pitcher L, Auerbach P. PMID: 11701191.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    197. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001 Jul; 156(2-3):117-54. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. PMID: 11549216.
      View in: PubMed   Mentions: 528     Fields:    Translation:HumansAnimals
    198. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001 Jul; 156(2-3):234-58. Braff DL, Geyer MA, Swerdlow NR. PMID: 11549226.
      View in: PubMed   Mentions: 610     Fields:    Translation:Humans
    199. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 2001 Jul; 156(2-3):194-215. Swerdlow NR, Geyer MA, Braff DL. PMID: 11549223.
      View in: PubMed   Mentions: 414     Fields:    Translation:Animals
    200. Measurement of startle response, prepulse inhibition, and habituation. Curr Protoc Neurosci. 2001 May; Chapter 8:Unit 8.7. Geyer MA, Swerdlow NR. PMID: 18428548.
      View in: PubMed   Mentions: 89     Fields:    Translation:Animals
    201. Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less. Brain Res Bull. 2001 May 01; 55(1):71-7. Swerdlow NR, Halim N, Hanlon FM, Platten A, Auerbach PP. PMID: 11427340.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    202. Obsessive-compulsive disorder and tic syndromes. Med Clin North Am. 2001 May; 85(3):735-55. Swerdlow NR. PMID: 11349482.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    203. Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization. Brain Res. 2001 Apr 20; 898(2):195-203. Swerdlow NR, Hanlon FM, Henning L, Kim YK, Gaudet I, Halim ND. PMID: 11306005.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    204. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001 Apr 15; 49(1-2):171-8. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. PMID: 11343875.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    205. Matching strategies for drug studies of prepulse inhibition in humans. Behav Pharmacol. 2001 Feb; 12(1):45-52. Swerdlow NR, Eastvold A, Uyan KM, Ploum Y, Cadenhead K. PMID: 11270511.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    206. Neuropathology in Tourette syndrome: an update. Adv Neurol. 2001; 85:151-61. Swerdlow NR, Young AB. PMID: 11530425.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    207. Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences. Neuropsychopharmacology. 2000 Dec; 23(6):623-32. Farid M, Martinez ZA, Geyer MA, Swerdlow NR. PMID: 11063918.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    208. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits. Neuropsychopharmacology. 2000 Nov; 23(5):517-27. Martinez ZA, Oostwegel J, Geyer MA, Ellison GD, Swerdlow NR. PMID: 11027917.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    209. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry. 2000 Oct; 157(10):1660-8. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. PMID: 11007721.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    210. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Psychopharmacology (Berl). 2000 Sep; 151(4):368-78. Swerdlow NR, Eastvold A, Gerbranda T, Uyan KM, Hartman P, Doan Q, Auerbach P. PMID: 11026744.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    211. Distributed neurodegenerative changes 2-28 days after ventral hippocampal excitotoxic lesions in rats. Brain Res. 2000 Aug 04; 873(1):60-74. Halim ND, Swerdlow NR. PMID: 10915811.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    212. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci. 2000 Jun 01; 20(11):4325-36. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA. PMID: 10818168; PMCID: PMC6772622.
      View in: PubMed   Mentions: 49     Fields:    Translation:Animals
    213. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol. 2000 Jun; 11(3-4):185-204. Swerdlow NR, Braff DL, Geyer MA. PMID: 11103873.
      View in: PubMed   Mentions: 134     Fields:    Translation:HumansAnimals
    214. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacol Biochem Behav. 2000 Mar; 65(3):449-57. Martinez ZA, Halim ND, Oostwegel JL, Geyer MA, Swerdlow NR. PMID: 10683485.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    215. Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment. Neuroscience. 2000; 96(3):523-36. Swerdlow NR, Taaid N, Halim N, Randolph E, Kim YK, Auerbach P. PMID: 10717433.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    216. Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology (Berl). 1999 Sep; 146(2):228-32. Swerdlow NR, Geyer MA, Hartman PL, Sprock J, Auerbach PP, Cadenhead K, Perry W, Braff DL. PMID: 10525760.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    217. Attitudes toward psychiatry as a prospective career among students entering medical school. Am J Psychiatry. 1999 Sep; 156(9):1397-402. Feifel D, Moutier CY, Swerdlow NR. PMID: 10484951.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    218. Preliminary findings with a new Vietnamese Stroop test. Percept Mot Skills. 1999 Aug; 89(1):173-82. Doan QT, Swerdlow NR. PMID: 10544412.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    219. Effects of LU-111995 in three models of disrupted prepulse inhibition in rats. J Pharmacol Exp Ther. 1999 Aug; 290(2):716-24. Geyer MA, Swerdlow NR, Lehmann-Masten V, Teschendorf HJ, Traut M, Gross G. PMID: 10411583.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    220. Visuospatial priming and stroop performance in patients with obsessive compulsive disorder. Neuropsychology. 1999 Jul; 13(3):447-57. Hartston HJ, Swerdlow NR. PMID: 10447305.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    221. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology. 1999 Jul; 21(1):28-39. Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. PMID: 10379517.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    222. Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci. 1999 Jun 29; 877:202-16. Swerdlow NR, Braff DL, Geyer MA. PMID: 10415651.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimals
    223. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry. 1999 Apr; 156(4):596-602. Braff DL, Swerdlow NR, Geyer MA. PMID: 10200740.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    224. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats. Psychopharmacology (Berl). 1999 Mar; 142(3):253-60. Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. PMID: 10208317.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    225. Saccadic performance characteristics and the behavioural neurology of Tourette's syndrome. J Neurol Neurosurg Psychiatry. 1999 Mar; 66(3):305-12. Farber RH, Swerdlow NR, Clementz BA. PMID: 10084528; PMCID: PMC1736262.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    226. Enhanced visual latent inhibition in obsessive-compulsive disorder. Biol Psychiatry. 1999 Feb 15; 45(4):482-8. Swerdlow NR, Hartston HJ, Hartman PL. PMID: 10071722.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    227. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry. 1999 Feb 01; 45(3):360-4. Cadenhead KS, Carasso BS, Swerdlow NR, Geyer MA, Braff DL. PMID: 10023514.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    228. Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task. J Clin Exp Neuropsychol. 1998 Dec; 20(6):873-84. Roman MJ, Delis DC, Filoteo JV, Demadura TL, Paulsen J, Swerdlow NR, Swenson MR, Salmon D, Butters N, Shults C. PMID: 10484698.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    229. What role models? Commentary on Robbins' homology in behavioural pharmacology: an approach to animal models of human cognition. Behav Pharmacol. 1998 Nov; 9(7):529-31. Swerdlow NR. PMID: 9862078.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    230. Startle in Tourette's syndrome. Biol Psychiatry. 1998 Nov 01; 44(9):935-6. Swerdlow NR. PMID: 9807655.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    231. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology (Berl). 1998 Nov; 140(1):75-80. Swerdlow NR, Bakshi V, Waikar M, Taaid N, Geyer MA. PMID: 9862405.
      View in: PubMed   Mentions: 34     Fields:    Translation:Animals
    232. Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behav Pharmacol. 1998 Sep; 9(5-6):389-96. Swerdlow NR, Taaid N, Oostwegel JL, Randolph E, Geyer MA. PMID: 9832924.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    233. Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. Pharmacol Biochem Behav. 1998 Sep; 61(1):113-9. Hart S, Zreik M, Carper R, Swerdlow NR. PMID: 9715813.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    234. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biol Psychiatry. 1998 Mar 15; 43(6):436-45. Bakshi VP, Swerdlow NR, Braff DL, Geyer MA. PMID: 9532349.
      View in: PubMed   Mentions: 31     Fields:    Translation:Animals
    235. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 1998; 24(2):285-301. Swerdlow NR, Geyer MA. PMID: 9613626.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansAnimals
    236. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology. 1998 Jan; 18(1):50-6. Swerdlow NR, Varty GB, Geyer MA. PMID: 9408918.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    237. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Res. 1997 Oct 31; 773(1-2):45-52. Kodsi MH, Swerdlow NR. PMID: 9409703.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    238. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Neurosci Lett. 1997 Aug 08; 231(2):103-7. Kodsi MH, Swerdlow NR. PMID: 9291151.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    239. The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin. Neurosci Lett. 1997 Jun 20; 229(1):5-8. Feifel D, Swerdlow NR. PMID: 9224788.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    240. The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Res. 1997 Jun 20; 760(1-2):80-4. Feifel D, Minor KL, Dulawa S, Swerdlow NR. PMID: 9237521.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    241. Characteristics of open- and closed-loop smooth pursuit responses among obsessive-compulsive disorder, schizophrenia, and nonpsychiatric individuals. Psychophysiology. 1997 Mar; 34(2):157-62. Farber RH, Clementz BA, Swerdlow NR. PMID: 9090264.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    242. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry. 1997 Feb 15; 41(4):452-60. Swerdlow NR, Hartman PL, Auerbach PP. PMID: 9034539.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    243. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience. 1997 Feb; 76(3):715-24. Wan FJ, Swerdlow NR. PMID: 9135045.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    244. Regulation of prepulse inhibition by ventral pallidal projections. Brain Res Bull. 1997; 43(2):219-28. Kodsi MH, Swerdlow NR. PMID: 9222535.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    245. Neuroanatomy of schizophrenia. Schizophr Bull. 1997; 23(3):509-12. Braff DL, Swerdlow NR. PMID: 9327513.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    246. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther. 1996 Dec; 279(3):1290-9. Swerdlow NR, Bakshi V, Geyer MA. PMID: 8968353.
      View in: PubMed   Mentions: 32     Fields:    Translation:Animals
    247. The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity. Eur J Pharmacol. 1996 Oct 24; 314(1-2):9-18. Wan FJ, Caine SB, Swerdlow NR. PMID: 8957213.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    248. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res. 1996 May 25; 722(1-2):168-76. Wan FJ, Swerdlow NR. PMID: 8813362.
      View in: PubMed   Mentions: 40     Fields:    Translation:Animals
    249. Latent inhibition in schizophrenia. Schizophr Res. 1996 May; 20(1-2):91-103. Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA. PMID: 8794497.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    250. Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology. 1996 Apr; 14(4):265-74. Wan FJ, Taaid N, Swerdlow NR. PMID: 8924194.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    251. Ocular motor responses to unpredictable and predictable smooth pursuit stimuli among patients with obsessive-compulsive disorder. J Psychiatry Neurosci. 1996 Jan; 21(1):21-8. Clementz BA, Farber RH, Lam MN, Swerdlow NR. PMID: 8580114; PMCID: PMC1188730.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    252. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behav Pharmacol. 1995 Dec; 6(8):801-809. Bakshi VP, Geyer MA, Taaid N, Swerdlow NR. PMID: 11224383.
      View in: PubMed   Mentions: 12     Fields:    
    253. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology (Berl). 1995 Nov; 122(1):27-34. Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA. PMID: 8711061.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    254. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl). 1995 Nov; 122(1):35-43. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. PMID: 8711062.
      View in: PubMed   Mentions: 83     Fields:    Translation:Animals
    255. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav Neurosci. 1995 Oct; 109(5):912-28. Kodsi MH, Swerdlow NR. PMID: 8554715.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    256. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology (Berl). 1995 Aug; 120(4):433-41. Wan FJ, Geyer MA, Swerdlow NR. PMID: 8539324.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    257. Drug screening in "normal" controls. Biol Psychiatry. 1995 Jul 15; 38(2):123-4. Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. PMID: 7578645.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    258. Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle. Brain Res. 1995 Jun 26; 684(1):26-35. Kodsi MH, Swerdlow NR. PMID: 7583201.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    259. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology. 1995 May; 45(5):951-6. Paulsen JS, Butters N, Sadek JR, Johnson SA, Salmon DP, Swerdlow NR, Swenson MR. PMID: 7746413.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    260. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology. 1995 Apr; 12(2):139-45. Caine SB, Geyer MA, Swerdlow NR. PMID: 7779242.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    261. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biol Psychiatry. 1995 Mar 01; 37(5):286-99. Swerdlow NR, Filion D, Geyer MA, Braff DL. PMID: 7748980.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    262. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 1995 Feb; 58(2):192-200. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR. PMID: 7876851; PMCID: PMC1073317.
      View in: PubMed   Mentions: 134     Fields:    Translation:Humans
    263. Gating and habituation deficits in the schizophrenia disorders. Clin Neurosci. 1995; 3(2):131-9. Braff DL, Swerdlow NR, Geyer MA. PMID: 7583619.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    264. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 1994 Nov; 271(2):787-94. Bakshi VP, Swerdlow NR, Geyer MA. PMID: 7965797.
      View in: PubMed   Mentions: 85     Fields:    Translation:Animals
    265. Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization. Pharmacol Biochem Behav. 1994 Sep; 49(1):155-63. Wan FJ, Geyer MA, Swerdlow NR. PMID: 7816867.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    266. Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of corticotropin releasing factor, but not strychnine. Psychopharmacology (Berl). 1994 Jun; 115(1-2):141-6. Swerdlow NR, Britton KT. PMID: 7862886.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    267. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine. Psychopharmacology (Berl). 1994 May; 114(4):675-8. Swerdlow NR, Zisook D, Taaid N. PMID: 7855231.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    268. Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res. 1994 Apr 18; 643(1-2):59-65. Kodsi MH, Swerdlow NR. PMID: 8032933.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    269. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 1994 Feb; 51(2):139-54. Swerdlow NR, Braff DL, Taaid N, Geyer MA. PMID: 8297213.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansAnimals
    270. Men are more inhibited than women by weak prepulses. Biol Psychiatry. 1993 Aug 15; 34(4):253-60. Swerdlow NR, Auerbach P, Monroe SM, Hartston H, Geyer MA, Braff DL. PMID: 8399822.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsPHPublic Health
    271. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav. 1993 Jul; 45(3):629-37. Swerdlow NR, Koob GF, Cador M, Lorang M, Hauger RL. PMID: 8392732.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    272. Dopamine and depression: circuitous logic? Biol Psychiatry. 1993 May 15; 33(10):757-8. Swerdlow NR. PMID: 8353174.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    273. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav. 1993 Mar; 44(3):741-4. Swerdlow NR, Geyer MA. PMID: 8451276.
      View in: PubMed   Mentions: 42     Fields:    Translation:Animals
    274. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry. 1993 Feb 15; 33(4):298-301. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL. PMID: 8471686.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    275. Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine tegmental nucleus. Behav Neurosci. 1993 Feb; 107(1):104-17. Swerdlow NR, Geyer MA. PMID: 8447948.
      View in: PubMed   Mentions: 43     Fields:    Translation:Animals
    276. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology (Berl). 1993; 113(1):103-9. Wan FJ, Swerdlow NR. PMID: 7862814.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    277. Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacol Biochem Behav. 1992 Dec; 43(4):1201-8. Caine SB, Geyer MA, Swerdlow NR. PMID: 1475305.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    278. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl). 1992; 108(1-2):189-95. Swerdlow NR, Caine SB, Geyer MA. PMID: 1410139.
      View in: PubMed   Mentions: 40     Fields:    Translation:Animals
    279. The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol. 1992 Jan; 6(2):176-90. Swerdlow NR, Caine SB, Braff DL, Geyer MA. PMID: 22291349.
      View in: PubMed   Mentions: 78     Fields:    
    280. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav. 1991 Dec; 40(4):841-5. Pulvirenti L, Swerdlow NR, Koob GF. PMID: 1687766.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    281. Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication. Neuropsychopharmacology. 1991 Aug; 5(1):23-31. Swerdlow NR, Hauger R, Irwin M, Koob GF, Britton KT, Pulvirenti L. PMID: 1657016.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    282. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther. 1991 Feb; 256(2):530-6. Swerdlow NR, Keith VA, Braff DL, Geyer MA. PMID: 1825226.
      View in: PubMed   Mentions: 54     Fields:    Translation:Animals
    283. Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 1991; 15(3):415-26. Swerdlow NR, Caine SB, Geyer MA. PMID: 1862221.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    284. Functional output of the basal forebrain. Adv Exp Med Biol. 1991; 295:291-305. Koob GF, Swerdlow NR, Vaccarino F, Hubner C, Pulvirenti L, Weiss F. PMID: 1776573.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    285. Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat. Psychopharmacology (Berl). 1991; 105(3):347-54. Caine SB, Geyer MA, Swerdlow NR. PMID: 1798831.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    286. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res. 1990 Nov 05; 532(1-2):146-50. Swerdlow NR, Braff DL, Geyer MA. PMID: 2282510.
      View in: PubMed   Mentions: 35     Fields:    Translation:Animals
    287. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull. 1990 Sep; 25(3):485-98. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL. PMID: 2292046.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansAnimalsCells
    288. Electroconvulsive therapy in a patient with severe tic and major depressive episode. J Clin Psychiatry. 1990 Jan; 51(1):34-5. Swerdlow NR, Gierz M, Berkowitz A, Nemiroff R, Lohr J. PMID: 2295590.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    289. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology (Berl). 1990; 102(1):1-4. Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA. PMID: 2392496.
      View in: PubMed   Mentions: 36     Fields:    Translation:Animals
    290. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl). 1990; 101(3):414-20. Swerdlow NR, Braff DL, Masten VL, Geyer MA. PMID: 2114026.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    291. Stress, performance, and arousal: focus on CRF. NIDA Res Monogr. 1990; 97:163-76. Koob GF, Cole BJ, Swerdlow NR, Le Moal M, Britton KT. PMID: 2174122.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    292. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berl). 1990; 100(3):413-6. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL. PMID: 2315438.
      View in: PubMed   Mentions: 51     Fields:    Translation:Animals
    293. Trazodone-fluoxetine combination for treatment of obsessive-compulsive disorder. Am J Psychiatry. 1989 Dec; 146(12):1637. Swerdlow NR, Andia AM. PMID: 2589561.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    294. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology. 1989 Dec; 2(4):285-92. Swerdlow NR, Britton KT, Koob GF. PMID: 2610824.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    295. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neurosci Lett. 1989 Aug 28; 103(2):213-8. Pulvirenti L, Swerdlow NR, Koob GF. PMID: 2771183.
      View in: PubMed   Mentions: 22     Fields:    Translation:Animals
    296. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine. Pharmacol Biochem Behav. 1989 Jul; 33(3):595-9. Swerdlow NR, Koob GF. PMID: 2511575.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    297. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behav Neurosci. 1988 Aug; 102(4):544-52. Gold LH, Swerdlow NR, Koob GF. PMID: 3139012.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    298. Depression in the aged. An overview. Psychiatr Clin North Am. 1988 Mar; 11(1):83-99. Ruegg RG, Zisook S, Swerdlow NR. PMID: 3288982.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    299. Acute postoperative delirium and extrapyramidal signs in a previously healthy parturient. Anesth Analg. 1988 Mar; 67(3):291-5. Weinger MB, Swerdlow NR, Millar WL. PMID: 3344981.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    300. The functional output of the mesolimbic dopamine system. Ann N Y Acad Sci. 1988; 537:216-27. Koob GF, Swerdlow NR. PMID: 3059925.
      View in: PubMed   Mentions: 37     Fields:    Translation:Animals
    301. Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. Life Sci. 1987 Jul 06; 41(1):41-9. Tazi A, Swerdlow NR, LeMoal M, Rivier J, Vale W, Koob GF. PMID: 3496511.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    302. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res. 1987 Jun 02; 412(2):233-43. Swerdlow NR, Koob GF. PMID: 3607466.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    303. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus. Pharmacol Biochem Behav. 1987 Apr; 26(4):765-9. Swerdlow NR, Amalric M, Koob GF. PMID: 3110795.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    304. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behavioral and Brain Sciences. 1987; 10:197-245. Swerdlow NR, Koob GF. View Publication.
    305. "Selective" D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat. Life Sci. 1986 Nov 24; 39(21):1985-93. Amalric M, Koob GF, Creese I, Swerdlow NR. PMID: 2946915.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    306. 'Catatonia' produced by alfentanil is reversed by methylnaloxonium microinjections into the brain. Brain Res. 1986 Oct 29; 386(1-2):287-95. Amalric M, Blasco TA, Smith NT, Lee DE, Swerdlow NR, Koob GF. PMID: 3022882.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    307. The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat. Brain Res. 1986 Oct 29; 386(1-2):280-6. Blasco TA, Lee D, Amalric M, Swerdlow NR, Smith NT, Koob GF. PMID: 3096494.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    308. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav. 1986 Jul; 25(1):233-48. Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF. PMID: 2875470.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    309. Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression? Biol Psychiatry. 1986 Jul; 21(8-9):775-86. Downs NS, Britton KT, Gibbs DM, Koob GF, Swerdlow NR. PMID: 3015269.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    310. Behavioral changes following central injection of cysteamine in rats. Brain Res. 1986 Feb 12; 365(1):159-63. Bakhit C, Swerdlow N. PMID: 2868783.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    311. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol Biochem Behav. 1986 Jan; 24(1):61-5. Vaccarino FJ, Amalric M, Swerdlow NR, Koob GF. PMID: 3080760.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    312. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry. 1986 Jan; 21(1):23-33. Swerdlow NR, Braff DL, Geyer MA, Koob GF. PMID: 3080033.
      View in: PubMed   Mentions: 71     Fields:    Translation:Animals
    313. The effects of verapamil on the locomotor-activating properties of corticotropin releasing factor (CRF) in the rat. Psychoneuroendocrinology. 1986; 11(2):237-40. Swerdlow NR, Koob GF, Aldenhoff JB. PMID: 3489244.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    314. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl). 1986; 88(2):147-52. Swerdlow NR, Geyer MA, Vale WW, Koob GF. PMID: 3081925.
      View in: PubMed   Mentions: 78     Fields:    Translation:Animals
    315. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat. J Pharmacol Exp Ther. 1985 Nov; 235(2):324-9. Swerdlow NR, Lee D, Koob GF, Vaccarino FJ. PMID: 3932641.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    316. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol Biochem Behav. 1985 Sep; 23(3):499-501. Swerdlow NR, Vaccarino FJ, Koob GF. PMID: 4048244.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    317. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat. Pharmacol Biochem Behav. 1985 Aug; 23(2):303-7. Swerdlow NR, Koob GF. PMID: 3877311.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    318. The neural substrates of apomorphine-stimulated locomotor activity following denervation of the nucleus accumbens. Life Sci. 1984 Dec 17; 35(25):2537-44. Swerdlow NR, Koob GF. PMID: 6096659.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    319. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology. 1984 Nov; 39(5):459-64. Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W. PMID: 6096752.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    320. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat. Neurosci Lett. 1984 Sep 07; 50(1-3):19-24. Swerdlow NR, Swanson LW, Koob GF. PMID: 6493625.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    321. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens. Brain Res. 1984 Jul 23; 306(1-2):141-8. Swerdlow NR, Swanson LW, Koob GF. PMID: 6087974.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    322. Restrained rats learn amphetamine-conditioned locomotion, but not place preference. Psychopharmacology (Berl). 1984; 84(2):163-6. Swerdlow NR, Koob GF. PMID: 6438675.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    323. Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety. Life Sci. 1983 May 02; 32(18):2087-93. Swerdlow NR, van der Kooy D, Koob GF, Wenger JR. PMID: 6843283.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    324. Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions. Brain Res. 1983 Jan 17; 259(1):111-8. van der Kooy D, Swerdlow NR, Koob GF. PMID: 6824923.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    325. The effect of tail pinch on the acoustic startle response in rats. Brain Res. 1982 Sep 09; 247(1):105-13. Sorenson CA, Swerdlow NR. PMID: 7127106.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    Neal's Networks
    Concepts (645)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (57)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California